Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion, |
RCV000014835 | SCV002572662 | likely pathogenic | Greig cephalopolysyndactyly syndrome | 2022-09-01 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. While this variant results in missense change, protein truncation variants are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.62; 3Cnet: 0.62). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with GLI3 -related disorder (ClinVar ID: VCV000013824 / PMID: 15739154). However, the evidence of pathogenicity is insufficient at this time. A different missense change at the same codon (p.Arg625Gln) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000528805). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. |
OMIM | RCV000014835 | SCV000035090 | pathogenic | Greig cephalopolysyndactyly syndrome | 2003-07-01 | no assertion criteria provided | literature only |